Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial.
Scholz CW, Pinto A, Linkesch W, Lindén O, Viardot A, Keller U, Hess G, Lastoria S, Lerch K, Frigeri F, Arcamone M, Stroux A, Frericks B, Pott C, Pezzutto A. Scholz CW, et al. Among authors: linkesch w. J Clin Oncol. 2013 Jan 20;31(3):308-13. doi: 10.1200/JCO.2011.41.1553. Epub 2012 Dec 10. J Clin Oncol. 2013. PMID: 23233718 Clinical Trial.
Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
Jäger G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, Neumann HJ, Mlineritsch B, DeSantis M, Quehenberger F, Chott A, Beham-Schmid C, Höfler G, Linkesch W, Raderer M. Jäger G, et al. Among authors: linkesch w. J Clin Oncol. 2002 Sep 15;20(18):3872-7. doi: 10.1200/JCO.2002.05.117. J Clin Oncol. 2002. PMID: 12228207 Clinical Trial.
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: registry analysis by the International Radioimmunotherapy Network.
Hohloch K, Delaloye AB, Windemuth-Kieselbach C, Gómez-Codina J, Linkesch W, Jurczak W, Cacchione R, Suh C, Zinzani PL, Trümper L. Hohloch K, et al. Among authors: linkesch w. J Nucl Med. 2011 Sep;52(9):1354-60. doi: 10.2967/jnumed.111.089920. Epub 2011 Aug 9. J Nucl Med. 2011. PMID: 21828114 Free article.
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Fridrik MA, Hausmaninger H, Linkesch W, Stöger M, Sill H, Neubauer M, Seewann HL, Klocker J, Haidinger R, Schiller L, Pont J, Raudaschl G, Falk M, Radaszkiewicz T. Fridrik MA, et al. Among authors: linkesch w. J Clin Oncol. 1996 Jan;14(1):227-32. doi: 10.1200/JCO.1996.14.1.227. J Clin Oncol. 1996. PMID: 8558202 Clinical Trial.
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Sezer O, Beksac M, Hajek R, Sucak G, Cagirgan S, Linkesch W, Meltem Akay O, Gülbas Z, Nahi H, Plesner T, Snowden JA, Timurağaoğlu A, Dechow T, Lang A, Tuğlular T, Drach J, Armbrecht G, Potamianou A, Couturier C, Olie RA, Feys C, Allietta N, Terpos E. Sezer O, et al. Among authors: linkesch w. Br J Haematol. 2017 Jul;178(1):61-71. doi: 10.1111/bjh.14637. Epub 2017 Apr 6. Br J Haematol. 2017. PMID: 28382618 Free article. Clinical Trial.
Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.
Jäger G, Neumeister P, Quehenberger F, Wöhrer S, Linkesch W, Raderer M. Jäger G, et al. Among authors: linkesch w. Ann Oncol. 2006 Nov;17(11):1722-3. doi: 10.1093/annonc/mdl126. Epub 2006 Jun 9. Ann Oncol. 2006. PMID: 16766585 Free article. Clinical Trial. No abstract available.
Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.
Hohloch K, Zinzani PL, Linkesch W, Jurczak W, Deptala A, Lorsbach M, Windemuth-Kiesselbach C, Wulf GG, Truemper LH. Hohloch K, et al. Among authors: linkesch w. Bone Marrow Transplant. 2011 Jun;46(6):901-3. doi: 10.1038/bmt.2010.202. Epub 2010 Sep 27. Bone Marrow Transplant. 2011. PMID: 20871640 No abstract available.
224 results